About Bondbay Pharmaceuticals
Bondbay Pharmaceuticals is a company based in Hyderabad (India) founded in 2007 by Sridhar Reddy. It operates as a B2B. Bondbay Pharmaceuticals offers products and services including APIs, Drug Intermediates, and R&D Services. Bondbay Pharmaceuticals operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter Hyderabad, India
- Founders Sridhar Reddy
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Ramis Laboratories Pvt. Ltd.
- Jurisdiction Quthubullapur Hyderabad, Telangana, India
-
Annual Revenue
$822.36 K (USD)17.71as on Mar 31, 2022
-
Net Profit
$22.63 K (USD)25.54as on Mar 31, 2022
-
EBITDA
$68.83 K (USD)1801.68as on Mar 31, 2022
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bondbay Pharmaceuticals
Bondbay Pharmaceuticals offers a comprehensive portfolio of products and services, including APIs, Drug Intermediates, and R&D Services.
Supplies active ingredients for generic drug manufacturing
Provides raw materials for pharmaceutical production processes
Offers development support for drug innovation and manufacturing
Funding Insights of Bondbay Pharmaceuticals
Detailed funding history for Bondbay Pharmaceuticals
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bondbay Pharmaceuticals
Investment portfolio details for Bondbay Pharmaceuticals
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bondbay Pharmaceuticals
Detailed financials for Bondbay Pharmaceuticals
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bondbay Pharmaceuticals Comparisons
Peer comparison for Bondbay Pharmaceuticals
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bondbay Pharmaceuticals
Bondbay Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical and biotechnology company
|
|
| Locked | Locked | Locked |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| Locked | Locked | Locked |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| Locked | Locked | Locked |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| Locked | Locked | Locked |
APIs are developed and manufactured for therapeutic areas.
|
|
| Locked | Locked | Locked |
Contract development, manufacturing, and analytical services for APIs are offered.
|
Detailed competitors of Bondbay Pharmaceuticals
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bondbay Pharmaceuticals
Complete news archive for Bondbay Pharmaceuticals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bondbay Pharmaceuticals
Bondbay Pharmaceuticals was founded in 2007.
Bondbay Pharmaceuticals is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Annual revenue of Bondbay Pharmaceuticals is $822.36K as on Mar 31, 2022.
Ramis Laboratories Pvt. Ltd. manufactures pharmaceutical raw materials, drug intermediates, and active pharmaceutical ingredients (APIs). They supply these to major generic drug companies and offer research and development services. Based in Hyderabad and Kadechur, India, they ensure high-quality standards through cGMP compliance and use high-grade raw materials. Their operations include formulation strategies for various treatments, focusing on innovation and client needs.
Bondbay Pharmaceuticals's top competitors include Laurus Labs, Symbiotec and Beijing Biostar Technologies.
Bondbay Pharmaceuticals offers APIs, Drug Intermediates, and R&D Services.